SEDAR Interim Financial Statements

[
  {
    "companyName": "Global Health Clinics Ltd.",
    "reportingPeriodEnd": "2025-10-31",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cash": 57680,
      "accountsReceivable": 955,
      "gstRecoverable": 6774,
      "totalCurrentAssets": 65409,
      "equipment": 1065,
      "totalNonCurrentAsset": 1065,
      "totalAssets": 66474,
      "accountsPayable": 1788488,
      "accruedLiabilities": 576500,
      "deferredRevenue": 1750,
      "loansPayable": 2560881,
      "totalCurrentLiabilities": 4927619,
      "totalLiabilities": 4927619,
      "shareCapital": 26342700,
      "reserves": 6831776,
      "accumulatedDeficit": -38035621,
      "totalShareholdersDeficiency": -4861145,
      "totalLiabilitiesAndShareholdersDeficiency": 66474,
      "cashPerShare": 0.0061,
      "workingCapitalPerShare": -0.5177
    },
    "incomeStatement": {
      "revenue": 2105,
      "costOfSales": -1625,
      "grossProfit": 480,
      "depreciation": 58,
      "bankChargesInterestAndAccretion": 68954,
      "consultingAndReferralFees": 72283,
      "filingAndListingFees": 2650,
      "legalAndProfessionalFees": 3792,
      "managementFees": 57000,
      "officeAndGeneralExpenses": 38585,
      "salariesAndWages": 89060,
      "transferAgentFees": 888,
      "netLossAndComprehensiveLoss": -332790,
      "basicAndDilutedNetLossPerShare": -0.04,
      "weightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": 9392138
    },
    "cashFlowStatement": {
      "netLossForThePeriod": -332790,
      "depreciation": 58,
      "accretionAndAccruedInterest": 68106,
      "changesInAccountsReceivable": 322,
      "changesInGstRecoverable": 6486,
      "changesInAccountsPayable": 90443,
      "changesInAccruedLiabilities": 23500,
      "changesInDeferredRevenue": 1070,
      "netCashUsedInOperatingActivities": -142805,
      "loanPayableNetOfRepayment": 150000,
      "netCashProvidedByFinancingActivity": 150000,
      "netChangeInCash": 7195,
      "cashBeginningOfPeriod": 50485,
      "cashEndOfPeriod": 57680
    },
    "investmentsAndOtherAssets": [],
    "shareStructure": {
      "authorizedShares": "unlimited common shares and unlimited Series A preferred shares",
      "issuedShares": 9392238,
      "classesOfShares": [
        "Common shares: 9,392,138 issued, no par value",
        "Series A preferred shares: 100 issued, non-voting, non-retractable, non-redeemable without dividend, no par value"
      ],
      "warrants": [],
      "options": [],
      "rightsConvertibleInstruments": null
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "2025": {
          "managementFees": 54000,
          "directorFees": 3000,
          "total": 57000
        },
        "2024": {
          "managementFees": 54000,
          "directorFees": 1000,
          "total": 55000
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "CEO",
          "description": "Accounts payable balance due",
          "amount": 769254,
          "period": "2025-10-31"
        },
        {
          "counterparty": "CFO",
          "description": "Accounts payable balance due",
          "amount": 115920,
          "period": "2025-10-31"
        },
        {
          "counterparty": "Director",
          "description": "Accounts payable balance due",
          "amount": 9000,
          "period": "2025-10-31"
        },
        {
          "counterparty": "CEO and other lenders",
          "description": "Loan payable including accrued interest (15% per annum)",
          "amount": 368974,
          "period": "2025-10-31"
        }
      ]
    },
    "subsequentEvents": []
  }
]